NeuroPace, Inc. (NPCE) vs SS Innovations International, Inc. (SSII)
- NeuroPace, Inc. NPCE 12.38 −2.44%
- SS Innovations International, Inc. SSII 2.20 +15.79%
NeuroPace, Inc. and SS Innovations International, Inc. are both Medical Devices companies. NeuroPace, Inc. is the larger, with a market value of $435.6M against $380.9M — 1.1× the size. SS Innovations International, Inc. grew revenue faster over the last twelve months: 89.7% against 11.6%. NeuroPace, Inc. has the higher net margin (−19.3% vs −23.7%) and the lower return on invested capital (−44.6% vs −11.3%). Across the 17 metrics below, SS Innovations International, Inc. leads on 9 and NeuroPace, Inc. on 8.
Valuation
Profitability
| Metric | NPCE | SSII | Medical Devices median |
|---|---|---|---|
| Gross margin | 81.57% | 47.65% | 57.76% |
| Operating margin | (13.87%) | (15.80%) | (15.07%) |
| Net margin | (19.34%) | (23.73%) | (14.45%) |
| Free cash flow margin | (11.75%) | (34.76%) | (3.88%) |
| Return on equity | (122.05%) | (26.06%) | (10.35%) |
| Return on assets | (18.82%) | (14.89%) | (17.26%) |
| Return on invested capital | (44.64%) | (11.31%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack